Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

Kissei logo

Kissei

Status and phase

Withdrawn
Phase 3

Conditions

Overactive Bladder

Treatments

Drug: KUC-7483

Study type

Interventional

Funder types

Industry

Identifiers

NCT01003405
KUC1302

Details and patient eligibility

About

To investigate the long-term safety, efficacy and pharmacokinetics of KUC-7483 in patients with overactive bladder.

Enrollment

100 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who have successfully completed the Phase III double-blind study.

Exclusion criteria

  • Patients with serious adverse events or clinically significant adverse events in the Phase III double-blind study.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

KUC-7483
Experimental group
Treatment:
Drug: KUC-7483

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems